Orthorexia Nervosa in Postmenopausal Osteoporosis
Launched by BEYLIKDUZU STATE HOSPITAL · Apr 20, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a condition called orthorexia nervosa in women who have osteoporosis. Osteoporosis is a health issue that makes bones weak and more likely to break. The researchers want to understand how the way people think about healthy eating (orthorexia) might affect women with osteoporosis compared to those who do not have this condition. They will look at 64 women with osteoporosis and 64 healthy women of similar age to gather information about their health, mood, and body image.
To participate, women need to be between 55 and 75 years old and have a recent diagnosis of osteoporosis. They will need to agree to take part in the study and provide written consent. Throughout the study, participants will answer questions about their eating habits, mood, and feelings about their bodies. This research may help improve our understanding of how mental and emotional factors relate to osteoporosis, which could lead to better support for women dealing with this condition.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women between 55-75 years
- • Women diagnosed with osteoporosis based on DXA measurements performed within the past six months.
- • Women aged similarly to the osteoporosis group without a diagnosis of osteoporosis (healthy controls).
- • Willingness to participate and provision of written informed consent.
- Exclusion Criteria:
- • Refusal to participate in the study.
- • Diagnosed psychiatric disorders.
- • Cognitive impairment.
- • Presence of malignancy.
- • Presence of endocrine disorders (e.g., hyperthyroidism, Cushing's syndrome).
- • Use of glucocorticoids.
- • Use of medications affecting mood.
About Beylikduzu State Hospital
Beylikduzu State Hospital is a leading healthcare institution located in Istanbul, Turkey, dedicated to advancing medical research and improving patient care through innovative clinical trials. As a government-funded facility, it prioritizes patient safety and ethical standards while fostering collaboration among healthcare professionals, researchers, and regulatory bodies. With a commitment to utilizing cutting-edge technology and evidence-based practices, Beylikduzu State Hospital aims to contribute significantly to the development of new therapies and treatment protocols that enhance health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported